Alpha Co Soft Capsule 1 Microgram (Alfacalcidol)

Adult dose

Chronic kidney failure/osteoporosis: Administer 0.5 to 1 ㎍ orally once daily as alfacalcidol. Hypoparathyroidism and diseases due to other vitamin D metabolism disorders: Administer 1 to 4 ㎍ orally once daily as this medication.

Child dose

Osteoporosis: Administer 0.01 to 0.03 ㎍ per kg of body weight orally once daily as alfacalcidol. Other conditions: Administer 0.05 to 0.1 ㎍ per kg of body weight orally once daily as this medication.

This medicine should not be taken by patients with hypercalcemia, hyperphosphatemia, or hypermagnesemia, which are conditions where calcium and phosphorus levels in the blood are elevated. Patients with alkalosis, caused by increased blood acidity levels, or those exhibiting toxic symptoms from excessive vitamin D intake should not use this medication. It should also be avoided if there is an allergy to any of the ingredients or vitamin D analogs in this medication. While taking this medication, it is important not to take drugs containing high levels of magnesium, vitamin D, calcium supplements, or certain diuretics concurrently. This medication is not recommended for breastfeeding women, and if it must be taken, breastfeeding should be avoided. Women who are pregnant or may become pregnant should use this medication only after consulting a physician due to potential effects on the fetus. Children, elderly patients, those taking certain medications, and individuals with conditions such as kidney stones or sarcoidosis should consult a professional before use. While taking this medication, serum calcium levels and kidney function should be regularly monitored, and if abnormalities are discovered, the medication should be discontinued immediately and medical consultation obtained. In case of overdose, various side effects can occur, including digestive disturbances, neurological issues, heart problems, kidney damage, liver dysfunction, skin rashes, eye problems, so caution is necessary. It is important to strictly adhere to the prescribed dosage and regimen and to manage calcium intake, while also being aware of symptoms of hypercalcemia. This medication should be stored out of reach of children, away from direct sunlight, in a cool, dry place. Furthermore, it is important not to transfer the medication to another container to maintain quality and prevent misuse.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in the oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory problems accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headache, seizures, confusion, vision problems, paralysis, urinary changes

Mild side effects

• Loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• stomach pain
• upper abdominal discomfort
• abdominal bloating
• indigestion
• thirst

This medication may be sensitive to light, so it should be stored in a tightly sealed container that blocks light. It is also recommended to store it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication over time.

Appearance

Orange oval soft capsule containing a colorless or transparent oily solution

Package unit

30 capsules/bottle, 100 capsules/bottle, 100 capsules/box [(10 capsules/PTP x 10)]